What is the growth forecast for the market?

The market is expected to grow at a CAGR of 10.3% from 2023 to 2028.

What are the key drivers of the market?

Increasing drug abuse cases and government initiatives drive the market.

What are the major challenges faced by the market?

Lack of awareness and high testing costs are significant challenges.

Which regions are the leaders in the market?

North America and Europe are the leading regions.

Who are the top companies in the market?

Top companies include LabCorp and Quest Diagnostics.

What are the future opportunities in the market?

Emerging economies and technological advancements offer opportunities.

How does technology impact the market?

Technological advancements improve testing accuracy and efficiency.

What is the regulatory landscape of the market?

Regulations vary by region, with strict laws in the US and EU.

What is the future outlook of the Drug or Substance Abuse Testing market?

The market is expected to grow significantly due to increasing demand.

Drug or Substance Abuse Testing Growth Drivers & Forecast Analysis 2033

Drug or Substance Abuse Testing by Application (Hospital, Judicial Body, Employment Screening, Rehabilitation Center, Others), by Types (Urine Testing, Saliva Testing, Blood Testing, Hair Testing), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 119

Forecast Period: 2026 - 2033

CAGR: 2019%

Historical Range: 2020 - 2025

Dec 13, 2025Updated: Jun 8, 2026

Pages: 119

Forecast Period: 2026 - 2033

CAGR: 2019%

Historical Range: 2020 - 2025

Dec 13, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Drug or Substance Abuse Testing Market Overview

The Drug or Substance Abuse Testing market refers to the industry that provides testing services and products to detect and prevent drug or substance abuse. As the Drug or Substance Abuse Testing market size is expected to grow significantly, driven by increasing awareness and stringent regulations, the growth outlook and market forecast are being closely watched by industry stakeholders. The industry expansion is expected to be driven by advances in technology, changes in consumer behavior, and evolving regulations. The current Drug or Substance Abuse Testing market size is approximately $4.8 billion. The market is expected to grow at a CAGR of 10.3% from 2026 to 2033, driven by macro drivers such as increasing drug abuse cases, growing demand for drug testing in workplaces, and rising awareness about substance abuse.

Loading chart…

Key forces shaping the Drug or Substance Abuse Testing industry include technology shifts, such as the development of point-of-care testing devices, regulations, such as the Mandatory Guidelines for Federal Workplace Drug Testing Programs, and consumer behavior, such as increasing demand for at-home testing kits. The largest region in the Drug or Substance Abuse Testing market is North America, while the fastest-growing region is expected to be the Asia-Pacific region. The competitive intensity in the market is high, with major players such as LabCorp, Quest Diagnostics, and Alere competing for market share. Overall, the Drug or Substance Abuse Testing market is expected to experience significant growth in the coming years, driven by increasing demand for testing services and products.

Report Overview

Report Attribute	Details
Market size value in 2025	20.61 million
Revenue forecast in 2033	837,771,622.25 billion
Growth rate	CAGR of XX% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Boto Bio; Meridian Bioscience; Abbott; BD; Dräger; LabCorp; Quest Diagnostics; Randox Testing Services; United States Drug Testing Laboratories Inc. (USDTL); Thermo Fisher Scientific Inc; Siemens Healthineers AG; F. Hoffmann-La Roche Ltd; Clinical Reference Laboratory Inc.; Cordant Health Solutions; Omega Laboratories Inc.; Psychemedics Corporation; Precision Diagnostics; Siemens Healthineers
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Drug or Substance Abuse Testing market is poised for significant growth, driven by increasing demand for effective testing solutions. The growth forecast for this market is substantial, with the global Drug or Substance Abuse Testing market size expected to expand rapidly over the next few years.

Growth Drivers2 items

Advancements in technology, such as the development of point-of-care testing devices, are driving growth in the Drug or Substance Abuse Testing market by enabling faster and more accurate testing.

Stringent regulatory requirements and increasing awareness about substance abuse are also fueling demand for effective testing solutions, contributing to the growth forecast of the market.

Restraints2 items

High costs associated with drug testing equipment and maintenance are limiting the adoption of these solutions, particularly among small and medium-sized organizations, and affecting the overall Drug or Substance Abuse Testing market size.

The lack of standardization in testing procedures and protocols is also hindering the growth of the Drug or Substance Abuse Testing market, as it creates challenges for companies to develop and implement effective testing solutions.

Opportunities2 items

The growing demand for on-site and point-of-care testing solutions is creating new opportunities for companies in the Drug or Substance Abuse Testing market to develop innovative and convenient testing products.

The increasing use of alternative specimens, such as oral fluid and hair, for drug testing is also opening up new avenues for growth in the Drug or Substance Abuse Testing market and contributing to its growth forecast.

Challenges2 items

The Drug or Substance Abuse Testing market faces challenges related to privacy concerns and data security, as testing solutions often involve the collection and storage of sensitive personal information.

The market is also subject to fluctuations in government funding and reimbursement policies, which can impact the demand for drug testing solutions and affect the overall Drug or Substance Abuse Testing market size.

Market Segmentation

Loading chart…

The Application segment in the Drug or Substance Abuse Testing market refers to the various areas where these tests are utilized. This includes workplace, criminal justice, sports, and medical applications. Each of these sub-segments contributes to the overall market size, with workplace testing being a significant contributor due to the increasing need for employers to maintain a safe and productive work environment. Understanding the Drug or Substance Abuse Testing segmentation is crucial for industry players to tailor their strategies according to the specific needs of each application area.

The Types segment in the Drug or Substance Abuse Testing market encompasses various subtypes, including urine, saliva, blood, and hair testing. Each subtype has its own advantages and is suited for different applications. For instance, urine testing is widely used due to its non-invasive nature and the ability to detect a broad range of substances. Analyzing the market taxonomy of these types helps in understanding the market dynamics and how each subtype contributes to the overall market size. The Drug or Substance Abuse Testing segmentation by types is essential for manufacturers to develop targeted products and for service providers to offer specialized testing solutions.

Drug or Substance Abuse Testing Segmentation Breakdown11 items

Application

Hospital

Judicial Body

Employment Screening

Rehabilitation Center

Others

Types

Urine Testing

Saliva Testing

Blood Testing

Hair Testing

Regional Insights

Loading chart…

The Drug or Substance Abuse Testing market growth is anticipated to vary across regions, with North America being the largest region, accounting for approximately 40% of the global market. The fastest-growing region is expected to be Asia Pacific, driven by increasing adoption of advanced testing technologies, favorable policies, and significant investments in healthcare infrastructure.

Key drivers for North America include a mature ecosystem, high demographics awareness, and stringent policies regulating substance abuse. In Europe, drivers include a well-established infrastructure, growing adoption of point-of-care testing, and increasing investments in research and development. Asia Pacific is driven by a large and growing demographics, increasing adoption of digital technologies, and rising investments in healthcare. Latin America and Middle East & Africa are driven by growing awareness of substance abuse, increasing adoption of testing technologies, and improving infrastructure.

The regional forecast indicates that North America will continue to dominate the market, while Asia Pacific will experience the highest Drug or Substance Abuse Testing market growth rate. The Latin America and Middle East & Africa regions will also witness significant growth, driven by increasing demand for substance abuse testing and improving ecosystem maturity.

Competitive Landscape

The Drug or Substance Abuse Testing market exhibits a moderately consolidated structure, driven by a mix of global players and local/regional companies. Key competitive levers include pricing, distribution, product innovation, certifications, and regulatory approvals. The Drug or Substance Abuse Testing competitive landscape is characterized by high competition, with companies focusing on differentiation through innovative products and services.

Companies in this market employ various strategies, including M&A, partnerships, product launches, expansion, R&D, and localization, to stay competitive. Competitive differentiation is achieved through technology, service model, channel strength, customization, and cost advantages. However, companies face challenges such as margin pressure, compliance costs, commoditization, and supply chain risks. The following companies have adopted distinct strategic focuses:

Abbott: regional expansion

BD: innovation pipeline

Dräger: premium pricing

LabCorp: vertical integration

Quest Diagnostics: OEM tie-ups

Randox Testing Services: local manufacturing

Key Drug or Substance Abuse Testing Companies18 items

Boto Bio

Meridian Bioscience

Abbott

Dräger

LabCorp

Quest Diagnostics

Randox Testing Services

United States Drug Testing Laboratories Inc. (USDTL)

Thermo Fisher Scientific Inc

Siemens Healthineers AG

F. Hoffmann-La Roche Ltd

Clinical Reference Laboratory Inc.

Cordant Health Solutions

Omega Laboratories Inc.

Psychemedics Corporation

Precision Diagnostics

Siemens Healthineers

Market Ecosystem

The Drug or Substance Abuse Testing ecosystem spans across upstream, midstream, and downstream segments, encompassing technology providers, integrators, channels, and end users. Value creation begins with raw material and component suppliers, followed by OEMs/manufacturers, and system integrators, before reaching distributors, service providers, and ultimately, end users. The Drug or Substance Abuse Testing ecosystem is characterized by the interplay of these stakeholders, where value is created and captured through the development, manufacturing, and deployment of testing solutions.

Raw material/component suppliers — providing testing reagents

OEMs / manufacturers — producing testing equipment

System integrators / EPCs — integrating testing systems

Distributors / channel partners — supplying testing solutions

Service providers / after-sales — offering maintenance and support

End users / buyers — utilizing testing solutions

Regulators/standards bodies — establishing testing protocols

The flow of value in the Drug or Substance Abuse Testing ecosystem is influenced by control points, such as regulatory approvals and standards, which can create bottlenecks and impact adoption. Dependency risks, including input constraints and switching costs, can also affect the ecosystem. Furthermore, partnerships and interoperability requirements between stakeholders can facilitate or hinder the exchange of value. A comprehensive value chain analysis is necessary to understand these dynamics and how they vary across regions, ultimately shaping the Drug or Substance Abuse Testing ecosystem.

Recent Industry Insights

The Drug or Substance Abuse Testing industry trends have witnessed significant developments over the last 12-18 months. Notable partnerships have been formed, such as collaborations between leading testing companies and research institutions, to enhance the accuracy and efficiency of testing methods. Additionally, there have been key mergers and acquisitions, with major players expanding their portfolios to include innovative testing technologies.

Recent product launches have also been observed, with a focus on point-of-care testing solutions and laboratory-based diagnostic kits. Furthermore, regulatory changes have been implemented to standardize testing protocols and ensure compliance with international standards. These developments indicate a shift in consumer and enterprise trends, with an increasing emphasis on prevention and early intervention strategies. Funding rounds and expansions have also been reported, with investors showing interest in the growth potential of the Drug or Substance Abuse Testing industry.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Drug or Substance Abuse Testing market outlook. The market attractiveness is moderate, driven by growing concerns about substance abuse and the need for effective testing solutions. The competitive intensity is high, with several key players operating in the market.

The long-term outlook for the Drug or Substance Abuse Testing market is positive, with increasing demand for innovative testing technologies. The innovation landscape is characterized by advancements in point-of-care testing and laboratory-based testing. However, the demand–supply balance is a key challenge, with some regions experiencing shortages of testing kits and supplies. Key risk factors include regulatory changes and litigation risks.

Overall, the Drug or Substance Abuse Testing market outlook is promising, with opportunities for growth and innovation. Decision-makers should focus on developing strategies to address the demand–supply imbalance and stay ahead of the competition in this rapidly evolving market.

11 items

1. Executive Summary

2. Drug or Substance Abuse Testing Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Drug or Substance Abuse Testing Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Drug or Substance Abuse Testing Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Hospital

6.1.2. Judicial Body

6.1.3. Employment Screening

6.1.4. Rehabilitation Center

6.1.5. Others

6.2. Global Drug or Substance Abuse Testing Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Urine Testing

6.2.2. Saliva Testing

6.2.3. Blood Testing

6.2.4. Hair Testing

6.3. Global Drug or Substance Abuse Testing Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Drug or Substance Abuse Testing Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Drug or Substance Abuse Testing Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Drug or Substance Abuse Testing Market Competition by Key Manufacturers

8.1. Global Drug or Substance Abuse Testing Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Drug or Substance Abuse Testing: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Boto Bio

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Meridian Bioscience

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Abbott

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. BD

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Dräger

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. LabCorp

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Quest Diagnostics

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Randox Testing Services

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. United States Drug Testing Laboratories Inc. (USDTL)

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Thermo Fisher Scientific Inc

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Siemens Healthineers AG

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. F. Hoffmann-La Roche Ltd

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. Clinical Reference Laboratory Inc.

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. Cordant Health Solutions

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

9.15. Omega Laboratories Inc.

9.15.1. Company Basic Information and Sales Area

9.15.2. Main Business/Business Overview

9.15.3. Product Portfolio

9.15.4. Financial

9.15.5. Recent Industry Insights

9.15.6. SWOT Analysis

9.16. Psychemedics Corporation

9.16.1. Company Basic Information and Sales Area

9.16.2. Main Business/Business Overview

9.16.3. Product Portfolio

9.16.4. Financial

9.16.5. Recent Industry Insights

9.16.6. SWOT Analysis

9.17. Precision Diagnostics

9.17.1. Company Basic Information and Sales Area

9.17.2. Main Business/Business Overview

9.17.3. Product Portfolio

9.17.4. Financial

9.17.5. Recent Industry Insights

9.17.6. SWOT Analysis

9.18. Siemens Healthineers

9.18.1. Company Basic Information and Sales Area

9.18.2. Main Business/Business Overview

9.18.3. Product Portfolio

9.18.4. Financial

9.18.5. Recent Industry Insights

9.18.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Drug or Substance Abuse Testing Market

Figure 4: Global Drug or Substance Abuse Testing Market: Drivers

Figure 5: Global Drug or Substance Abuse Testing Market: Challenges

Figure 6: Global Drug or Substance Abuse Testing Market: Trends

Figure 7: Global Drug or Substance Abuse Testing Market: Opportunity

Figure 8: Global Drug or Substance Abuse Testing Market: Restraint

Figure 9: Global Drug or Substance Abuse Testing Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Drug or Substance Abuse Testing Market Value (USD Million) By Region

Figure 15: Global Drug or Substance Abuse Testing Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Drug or Substance Abuse Testing Market Value (USD Million) By Region

Figure 23: Global Drug or Substance Abuse Testing Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

89 items

Table 1: Market Segmentation Analysis

Table 2: Global Drug or Substance Abuse Testing Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Drug or Substance Abuse Testing Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Drug or Substance Abuse Testing Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Drug or Substance Abuse Testing Market Value (USD Million) By Region

Table 10: Global Drug or Substance Abuse Testing Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Drug or Substance Abuse Testing Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Drug or Substance Abuse Testing Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Drug or Substance Abuse Testing Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Boto Bio Basic Information And Sales Area

Table 31: Boto Bio. Products Portfolio

Table 32: Meridian Bioscience Basic Information And Sales Area

Table 33: Meridian Bioscience. Products Portfolio

Table 34: Abbott Basic Information And Sales Area

Table 35: Abbott. Products Portfolio

Table 36: BD Basic Information And Sales Area

Table 37: BD. Products Portfolio

Table 38: Dräger Basic Information And Sales Area

Table 39: Dräger. Products Portfolio

Table 40: LabCorp Basic Information And Sales Area

Table 41: LabCorp. Products Portfolio

Table 42: Quest Diagnostics Basic Information And Sales Area

Table 43: Quest Diagnostics. Products Portfolio

Table 44: Randox Testing Services Basic Information And Sales Area

Table 45: Randox Testing Services. Products Portfolio

Table 46: United States Drug Testing Laboratories Inc. (USDTL) Basic Information And Sales Area

Table 47: United States Drug Testing Laboratories Inc. (USDTL). Products Portfolio

Table 48: Thermo Fisher Scientific Inc Basic Information And Sales Area

Table 49: Thermo Fisher Scientific Inc. Products Portfolio

Table 50: Siemens Healthineers AG Basic Information And Sales Area

Table 51: Siemens Healthineers AG. Products Portfolio

Table 52: F. Hoffmann-La Roche Ltd Basic Information And Sales Area

Table 53: F. Hoffmann-La Roche Ltd. Products Portfolio

Table 54: Clinical Reference Laboratory Inc. Basic Information And Sales Area

Table 55: Clinical Reference Laboratory Inc.. Products Portfolio

Table 56: Cordant Health Solutions Basic Information And Sales Area

Table 57: Cordant Health Solutions. Products Portfolio

Table 58: Omega Laboratories Inc. Basic Information And Sales Area

Table 59: Omega Laboratories Inc.. Products Portfolio

Table 60: Psychemedics Corporation Basic Information And Sales Area

Table 61: Psychemedics Corporation. Products Portfolio

Table 62: Precision Diagnostics Basic Information And Sales Area

Table 63: Precision Diagnostics. Products Portfolio

Table 64: Siemens Healthineers Basic Information And Sales Area

Table 65: Siemens Healthineers. Products Portfolio

Table 66: Global Market Value (USD Million) (2025-2032) By Application

Table 67: Global Market Share (%) By Application (2032)

Table 68: Global Market Value (USD Million) (2025-2032) By Types

Table 69: Global Market Share (%) By Types (2032)

Table 70: Global Drug or Substance Abuse Testing Market Value (USD Million) By Region

Table 71: Global Drug or Substance Abuse Testing Market Share (%) By Region (2025-2032)

Table 72: North America Market Value (USD Million) (2025-2032) By Country

Table 73: North America Market Value (USD Million) (2025-2032) By Application

Table 74: North America Market Value (USD Million) (2025-2032) By Types

Table 75: Europe Market Value (USD Million) (2025-2032) By Country

Table 76: Europe Market Value (USD Million) (2025-2032) By Application

Table 77: Europe Market Value (USD Million) (2025-2032) By Types

Table 78: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 79: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 80: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 81: South America Market Value (USD Million) (2025-2032) By Country

Table 82: South America Market Value (USD Million) (2025-2032) By Application

Table 83: South America Market Value (USD Million) (2025-2032) By Types

Table 84: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 85: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 86: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 87: Research Programs/Design For This Report

Table 88: Key Data Information From Secondary Sources

Table 89: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Drug or Substance Abuse Testing Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	20.61 million
Revenue forecast in 2033	837,771,622.25 billion
Growth rate	CAGR of XX% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Boto Bio; Meridian Bioscience; Abbott; BD; Dräger; LabCorp; Quest Diagnostics; Randox Testing Services; United States Drug Testing Laboratories Inc. (USDTL); Thermo Fisher Scientific Inc; Siemens Healthineers AG; F. Hoffmann-La Roche Ltd; Clinical Reference Laboratory Inc.; Cordant Health Solutions; Omega Laboratories Inc.; Psychemedics Corporation; Precision Diagnostics; Siemens Healthineers
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Stringent regulatory requirements and increasing awareness about substance abuse are also fueling demand for effective testing solutions, contributing to the growth forecast of the market.

Restraints2 items

Opportunities2 items

Challenges2 items

Market Segmentation

Loading chart…

Drug or Substance Abuse Testing Segmentation Breakdown11 items

Application

Hospital

Judicial Body

Employment Screening

Rehabilitation Center

Others

Types

Urine Testing

Saliva Testing

Blood Testing

Hair Testing

Regional Insights

Loading chart…

Competitive Landscape

Abbott: regional expansion

BD: innovation pipeline

Dräger: premium pricing

LabCorp: vertical integration

Quest Diagnostics: OEM tie-ups

Randox Testing Services: local manufacturing

Key Drug or Substance Abuse Testing Companies18 items

Boto Bio

Meridian Bioscience

Abbott

Dräger

LabCorp

Quest Diagnostics

Randox Testing Services

United States Drug Testing Laboratories Inc. (USDTL)

Thermo Fisher Scientific Inc

Siemens Healthineers AG

F. Hoffmann-La Roche Ltd

Clinical Reference Laboratory Inc.

Cordant Health Solutions

Omega Laboratories Inc.

Psychemedics Corporation

Precision Diagnostics

Siemens Healthineers

Market Ecosystem

Raw material/component suppliers — providing testing reagents

OEMs / manufacturers — producing testing equipment

System integrators / EPCs — integrating testing systems

Distributors / channel partners — supplying testing solutions

Service providers / after-sales — offering maintenance and support

End users / buyers — utilizing testing solutions

Regulators/standards bodies — establishing testing protocols

Recent Industry Insights

Analyst Overview

Table of Contents